Facebook Twitter LinkedIn YouTube Instagram

To navigate the following site navigation expect to utilize the tab key to move through items sequentially. The spacebar or enter keys can be utilized to interact with items that open sub-navigation.

The next tab will be the search box toggle. Hit enter to open the search, focus will automatically shift to the search bar. Type a letter into the search input and suggested results will appear.

Drug

iNO

Status:

Phase 3

Condition:

Lung Transplant

Intervention Type:

Inhaled Drug

Funder Type:

Organization | University

Drug Details

iNO stands for Inhaled Nitric Oxide. Nitric oxide is a colorless gas that is formed by the oxidation of nitrogen.

Study Purpose

To conduct a clinical investigation to determine if inhaled epoprostenol (Veletri®, iEPO) and inhaled nitric oxide (iNO) will have similar impact on outcomes in adult patients undergoing durable LVAD placement, heart transplantation, or lung transplantation 2. to conduct a cost-capture analysis on the expense each drug incurs per patient.

This drug has no clinical trials actively recruiting patients at this time.